LncRNA HOTAIR Regulates CCND1 and CCND2 Expression by Sponging miR-206 in Ovarian Cancer

被引:114
|
作者
Chang, Lei [1 ]
Guo, Ruixia [1 ]
Yuan, Zhongfu [1 ]
Shi, Huirong [1 ]
Zhang, Dongya [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Gynecol, 1 East Jianshe Rd, Zhengzhou 450000, Henan, Peoples R China
基金
中国博士后科学基金;
关键词
LncRNA HOTAIR; miR-206; CCND1; CCND2; Ovarian cancer; COMPETING ENDOGENOUS RNA; LONG NONCODING RNAS; CYCLIN D1; CELL-CYCLE; PROGRESSION; OVEREXPRESSION; PROLIFERATION; MICRORNAS; OSTEOSARCOMA; PROGNOSIS;
D O I
10.1159/000493408
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background/Aims: The long noncoding RNA homeobox (HOX) transcript antisense intergenic RNA (HOTAIR) has been demonstrated to be a vital modulator in the proliferation and metastasis of ovarian cancer cells, but its potential molecular mechanism remains to be elucidated. In the current study, we aimed to uncover the biological role of IncRNA HOTAIR and its underlying regulatory mechanism in the progression and metastasis of ovarian cancer. Methods: HOTAIR expression was detected by quantitative RT-PCR (qRT-PCR) and northern blotting. The SKOV3 ovarian cancer cell line was chosen for the subsequent assays. In addition, the molecular mRNA and protein expression levels were examined by qRT-PCR and western blotting. The competitive endogenous RNA (ceRNA) mechanism was validated by bioinformatics analysis and a dual luciferase reporter gene assay. Results: HOTAIR expression was significantly higher in ovarian carcinoma tissues and cell lines than in the control counterparts. Both CCND1 and CCND2 were downstream targets of miR-206. The inhibition of HOTAIR elevated the expression of miR-206 and inhibited the expression of CCND1 and CCND2. Moreover, CCND1 and CCND2 were highly expressed in ovarian cancer tissues, and their expression was positively correlated with HOTAIR expression. Finally, the functional assays indicated that the anticancer effects of miR-206 could be rescued by the simultaneous overexpression of either CCND1 or CCND2 in ovarian cancer. Conclusion: HOTAIR enhanced CCND1 and CCND2 expression by negatively modulating miR-206 expression and stimulating the proliferation, cell cycle progression, migration and invasion of ovarian cancer cells. (C) 2018 The Author(s) Published by S. Karger AG, Basel
引用
收藏
页码:1289 / 1303
页数:15
相关论文
共 50 条
  • [31] lncRNA FLVCR-AS1 promotes osteosarcoma growth by targeting miR381-3p/CCND1
    Yang, Guang
    He, Fei
    Duan, Hao
    Shen, Jianlin
    Dong, Qirong
    ONCOTARGETS AND THERAPY, 2020, 13 : 163 - 172
  • [32] MiR-188-5p inhibits cell proliferation and migration in ovarian cancer via competing for CCND2 with ELAVL1
    Zhang, Hongying
    Yuan, Ningxia
    Che, Hongcai
    Cheng, Xifeng
    CELLULAR AND MOLECULAR BIOLOGY, 2023, 69 (03) : 69 - 74
  • [33] circ-CCND1 regulates the CCND1/P53/P21 pathway through sponging miR-138-5p in valve interstitial cells to aggravate aortic valve calcification
    Fei Yan
    Xiang Xie
    Qiang Huo
    Weimin Zhang
    Tingting Wu
    Lin Daniyaer·Dilimulati
    Journal of Physiology and Biochemistry, 2022, 78 : 845 - 854
  • [34] miR-1247-3p regulation of CCND1 affects chemoresistance in colorectal cancer
    Wang, Dequan
    Wang, Jielian
    Yao, Fei
    Xie, Zhufu
    Wu, Jianze
    Chen, Huiguang
    Wu, Qingming
    PLOS ONE, 2024, 19 (12):
  • [35] LncRNA NEAT1 accelerates breast cancer progression through regulating miR-410-3p/CCND1 axis
    Liu, Xuan
    Yao, Weirong
    Xiong, Haiwei
    Li, Qiang
    Li, Yingliang
    CANCER BIOMARKERS, 2020, 29 (02) : 277 - 290
  • [36] Synthetic lethality of ERBB2 and CCND1 in breast cancer at scale
    Nair, Rishi
    White, Evan P.
    Khalife, Roy
    Magliocco, Anthony M.
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (06)
  • [37] lncRNA TUG1 Promotes Cisplatin Resistance by Regulating CCND2 via Epigenetically Silencing miR-194-5p in Bladder Cancer
    Yu, Gan
    Zhou, Hui
    Yao, Weimin
    Meng, Lirong
    Lang, Bin
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2019, 16 : 257 - 271
  • [38] CCND1 messenger RNA expression is correlated with EGFR mutation status in lung cancer
    Sasaki, Hidefumi
    Okuda, Katsuhiro
    Endo, Katsuhiko
    Kawano, Osamu
    Yukiue, Haruhiro
    Yokoyama, Tomoki
    Yano, Motoki
    Fujii, Yoshitaka
    CLINICAL LUNG CANCER, 2007, 8 (08) : 493 - 496
  • [39] Prognostic significance of cyclin D1 gene (CCND1) polymorphism in epithelial ovarian cancer
    Dhar, KK
    Branigan, K
    Howells, REJ
    Musgrove, C
    Jones, PW
    Strange, RC
    Fryer, AA
    Redman, CWE
    Hoban, PR
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1999, 9 (04) : 342 - 347
  • [40] ITGA2 promotes expression of ACLY and CCND1 in enhancing breast cancer stemness and metastasis
    Adorno-Cruz, Valery
    Hoffmann, Andrew D.
    Liu, Xia
    Dashzeveg, Nurmaa K.
    Taftaf, Rokana
    Wray, Brian
    Keri, Ruth A.
    Liu, Huiping
    GENES & DISEASES, 2021, 8 (04) : 493 - 508